DOI:
VOLUME-5, ISSUE-4
Yadav Punita, Mishra Manoj Kumar, Gautam Singh Shekhar, SahuAtulKumar, Prasad Raj Keshwar
Department of Pharmaceutics, Shambhunath Institute of Pharmacy, Jhalwa, Allahabad, Uttar Pradesh, India-211012Correspondence
ABSTRACT
Background:Co-crystallization is the process to enhance the physical properties of the molecule, especially the solubility and dissolution rate. The physical and chemical property improvements through pharmaceutical co-crystals draw closer the fields of crystal engineering and pharmaceutical science. Objective:In this work BCS Class II drug Cilnidipine is used as a model drug, which is having poor solubility but high permeability is incorporated with urea to enhance bioavailability and dissolution rate.Methods:Co-crystals are formed by solvent evaporation and solvent drop grinding method with urea and benzoic acid as a co-formers. Methanol is used as a solvent.Result:Differential Scanning Calorimetry (DSC) and Powder X-ray Diffraction (PXRD) and FTIR techniques were employed to support the formation of co-crystals and to find out the optimized ratio of components of co-crystals.Conclusion: All the prepared co-crystals showed high solubility to the parent drug. Based on the formulation development and their results, co-crystals engineering is viable alternative to increase the aqueous solubility of poorly soluble drugs, which ultimately increases dissolution profile and bioavailability
Keywords: Co-crystallization, Cilnidipine, Urea, Benzoic Acid, Methanol